OCCUDO QUANTITATIVE STRATEGIES LP
Position in RPRX — Royalty Pharma plc
CIK 1819697
FORT LAUDERDALE, FL
Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,842,746
+$3,402,777 QoQ
Shares Held
121,800
+55.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OCCUDO QUANTITATIVE STRATEGIES LP holds $11,453,802 across 11 Biotechnology names. RPRX ranks #1 (51.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
121,800 | $5,842,746 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
13,826 | $2,336,870 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,669 | $1,730,530 | |
| 4 | NKTR |
Nektar Therapeutics
|
8,948 | $643,808 | |
| 5 | PHVS |
Pharvaris N.V.
|
11,364 | $321,033 | |
| 6 | ALMS |
Alumis Inc.
|
11,124 | $245,061 | |
| 7 | ACET |
Adicet Bio, Inc.
|
15,100 | $102,831 | |
| 8 | COYA |
Coya Therapeutics, Inc.
|
23,642 | $93,149 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,842,746 | 121,800 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $2,439,969 | 78,380 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $574,281 | 22,512 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $324,203 | 11,460 | Shares | Sole | 2024-11-14 | |
| 2022-09-30 | $889,946 | 22,149 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $986,043 | 27,284 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,948,205 | 71,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,577,866 | 36,173 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $414,564 | 8,283 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||